Article Versions Notes

Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz Ov, Holvec S, Malaval J-L, Winum J-Y, Klaholz BP, Peyron J-F. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020; 9(3):629. https://doi.org/10.3390/cells9030629

Gilles, Arnaud, Léo Frechin, Kundhavai Natchiar, Giulia Biondani, Ottilie von Loeffelholz, Samuel Holvec, Julie-Lisa Malaval, Jean-Yves Winum, Bruno P. Klaholz, and Jean-François Peyron. 2020. "Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies" Cells 9, no. 3: 629. https://doi.org/10.3390/cells9030629

Gilles, A., Frechin, L., Natchiar, K., Biondani, G., Loeffelholz, O. v., Holvec, S., Malaval, J. -L., Winum, J. -Y., Klaholz, B. P., & Peyron, J. -F. (2020). Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells, 9(3), 629. https://doi.org/10.3390/cells9030629